ArticleRSC advances2022
Synthesis and characterisation of heteroatom-doped reduced graphene oxide/bismuth oxide nanocomposites and their application as photoanodes in DSSCs.
Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Toxic Effects of Synthesized Bismuth Oxide/Reduced Graphene Oxide (BiInternational journal of nanomedicine · 2024Article
- Delafossite CuCoORSC advances · 2023Article
- The Anticancer Efficacy of Thiourea-Mediated Reduced Graphene Oxide Nanosheets against Human Colon Cancer Cells (HT-29).Journal of functional biomaterials · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Semiconductor materials have been recently employed in photovoltaic devices, particularly dye-sensitized solar cells (DSSCs), to solve numerous global issues, especially the current energy crisis emanating from the depletion and hazardous nature of conventional energy sources, such as fossil fuels and nuclear energy. However, progress for the past years has been mainly limited by poor electron injection and charge carrier recombination experienced by DSSCs at the photoanode. Thus, novel semiconductor materials such as bismuth oxide (Bi
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.